aluates Reports

$ 0.0

Automative

Global Monkeypox Vaccine Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-17F11344

Global Monkeypox Vaccine Market Research Report 2022

BUY CHAPTERS

Global Monkeypox Vaccine Market Research Report 2024

Code: QYRE-Auto-17F11344

Report

June 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bavarian Nordic inks

Monkeypox Vaccine Market Size

The global Monkeypox Vaccine market was valued at US$ 5 million in 2023 and is anticipated to reach US$ 10 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

Monkeypox Vaccine Market

Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Monkeypox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Vaccine.

Report Scope

The Monkeypox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monkeypox Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monkeypox Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monkeypox Vaccine Market Report

Report Metric	Details
Report Name	Monkeypox Vaccine Market
Accounted market size in 2023	US$ 5 million
Forecasted market size in 2030	US$ 10 million
CAGR	5.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	DNA Non-replicating Viral Vector Protein Subunit RNA Others
Segment by Application	Aldult Child
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bavarian Nordic inks
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monkeypox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monkeypox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Monkeypox Vaccine Market growing?

Ans: The Monkeypox Vaccine Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Monkeypox Vaccine Market size in 2030?

Ans: The Monkeypox Vaccine Market size in 2030 will be US$ 10 million.

Who are the main players in the Monkeypox Vaccine Market report?

Ans: The main players in the Monkeypox Vaccine Market are Bavarian Nordic inks

What are the Application segmentation covered in the Monkeypox Vaccine Market report?

Ans: The Applications covered in the Monkeypox Vaccine Market report are Aldult, Child

What are the Type segmentation covered in the Monkeypox Vaccine Market report?

Ans: The Types covered in the Monkeypox Vaccine Market report are DNA, Non-replicating Viral Vector, Protein Subunit, RNA, Others

1 Monkeypox Vaccine Market Overview

1.1 Product Overview and Scope of Monkeypox Vaccine

1.2 Monkeypox Vaccine Segment by Type

1.2.1 Global Monkeypox Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 DNA

1.2.3 Non-replicating Viral Vector

1.2.4 Protein Subunit

1.2.5 RNA

1.2.6 Others

1.3 Monkeypox Vaccine Segment by Application

1.3.1 Global Monkeypox Vaccine Market Value by Application: (2024-2030)

1.3.2 Aldult

1.3.3 Child

1.4 Global Monkeypox Vaccine Market Size Estimates and Forecasts

1.4.1 Global Monkeypox Vaccine Revenue 2019-2030

1.4.2 Global Monkeypox Vaccine Sales 2019-2030

1.4.3 Global Monkeypox Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Monkeypox Vaccine Market Competition by Manufacturers

2.1 Global Monkeypox Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Monkeypox Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Monkeypox Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Monkeypox Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Monkeypox Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Monkeypox Vaccine, Product Type & Application

2.7 Monkeypox Vaccine Market Competitive Situation and Trends

2.7.1 Monkeypox Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Monkeypox Vaccine Players Market Share by Revenue

2.7.3 Global Monkeypox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Monkeypox Vaccine Retrospective Market Scenario by Region

3.1 Global Monkeypox Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Monkeypox Vaccine Global Monkeypox Vaccine Sales by Region: 2019-2030

3.2.1 Global Monkeypox Vaccine Sales by Region: 2019-2024

3.2.2 Global Monkeypox Vaccine Sales by Region: 2025-2030

3.3 Global Monkeypox Vaccine Global Monkeypox Vaccine Revenue by Region: 2019-2030

3.3.1 Global Monkeypox Vaccine Revenue by Region: 2019-2024

3.3.2 Global Monkeypox Vaccine Revenue by Region: 2025-2030

3.4 North America Monkeypox Vaccine Market Facts & Figures by Country

3.4.1 North America Monkeypox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Monkeypox Vaccine Sales by Country (2019-2030)

3.4.3 North America Monkeypox Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Monkeypox Vaccine Market Facts & Figures by Country

3.5.1 Europe Monkeypox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Monkeypox Vaccine Sales by Country (2019-2030)

3.5.3 Europe Monkeypox Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Monkeypox Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Monkeypox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Monkeypox Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Monkeypox Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Monkeypox Vaccine Market Facts & Figures by Country

3.7.1 Latin America Monkeypox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Monkeypox Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Monkeypox Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Monkeypox Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Monkeypox Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Monkeypox Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Monkeypox Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Monkeypox Vaccine Sales by Type (2019-2030)

4.1.1 Global Monkeypox Vaccine Sales by Type (2019-2024)

4.1.2 Global Monkeypox Vaccine Sales by Type (2025-2030)

4.1.3 Global Monkeypox Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Monkeypox Vaccine Revenue by Type (2019-2030)

4.2.1 Global Monkeypox Vaccine Revenue by Type (2019-2024)

4.2.2 Global Monkeypox Vaccine Revenue by Type (2025-2030)

4.2.3 Global Monkeypox Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Monkeypox Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Monkeypox Vaccine Sales by Application (2019-2030)

5.1.1 Global Monkeypox Vaccine Sales by Application (2019-2024)

5.1.2 Global Monkeypox Vaccine Sales by Application (2025-2030)

5.1.3 Global Monkeypox Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Monkeypox Vaccine Revenue by Application (2019-2030)

5.2.1 Global Monkeypox Vaccine Revenue by Application (2019-2024)

5.2.2 Global Monkeypox Vaccine Revenue by Application (2025-2030)

5.2.3 Global Monkeypox Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Monkeypox Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bavarian Nordic inks

6.1.1 Bavarian Nordic inks Corporation Information

6.1.2 Bavarian Nordic inks Description and Business Overview

6.1.3 Bavarian Nordic inks Monkeypox Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bavarian Nordic inks Monkeypox Vaccine Product Portfolio

6.1.5 Bavarian Nordic inks Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Monkeypox Vaccine Industry Chain Analysis

7.2 Monkeypox Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Monkeypox Vaccine Production Mode & Process

7.4 Monkeypox Vaccine Sales and Marketing

7.4.1 Monkeypox Vaccine Sales Channels

7.4.2 Monkeypox Vaccine Distributors

7.5 Monkeypox Vaccine Customers

8 Monkeypox Vaccine Market Dynamics

8.1 Monkeypox Vaccine Industry Trends

8.2 Monkeypox Vaccine Market Drivers

8.3 Monkeypox Vaccine Market Challenges

8.4 Monkeypox Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bavarian Nordic inks

List of Tables

Table 1. Global Monkeypox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Monkeypox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Monkeypox Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Monkeypox Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Monkeypox Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Monkeypox Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Monkeypox Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Monkeypox Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Monkeypox Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Monkeypox Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Monkeypox Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Monkeypox Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Monkeypox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Monkeypox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Monkeypox Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Monkeypox Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Monkeypox Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Monkeypox Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Monkeypox Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Monkeypox Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Monkeypox Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Monkeypox Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Monkeypox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Monkeypox Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Monkeypox Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Monkeypox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Monkeypox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Monkeypox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Monkeypox Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Monkeypox Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Monkeypox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Monkeypox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Monkeypox Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Monkeypox Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Monkeypox Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Monkeypox Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Monkeypox Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Monkeypox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Monkeypox Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Monkeypox Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Monkeypox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Monkeypox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Monkeypox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Monkeypox Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Monkeypox Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Monkeypox Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Monkeypox Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Monkeypox Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Monkeypox Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Monkeypox Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Monkeypox Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Monkeypox Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Monkeypox Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Monkeypox Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Monkeypox Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Monkeypox Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Monkeypox Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Monkeypox Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Monkeypox Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Monkeypox Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Monkeypox Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Monkeypox Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Monkeypox Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Monkeypox Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Monkeypox Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Monkeypox Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Monkeypox Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Bavarian Nordic inks Corporation Information

Table 71. Bavarian Nordic inks Description and Business Overview

Table 72. Bavarian Nordic inks Monkeypox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bavarian Nordic inks Monkeypox Vaccine Product

Table 74. Bavarian Nordic inks Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Monkeypox Vaccine Distributors List

Table 78. Monkeypox Vaccine Customers List

Table 79. Monkeypox Vaccine Market Trends

Table 80. Monkeypox Vaccine Market Drivers

Table 81. Monkeypox Vaccine Market Challenges

Table 82. Monkeypox Vaccine Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Monkeypox Vaccine

Figure 2. Global Monkeypox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Monkeypox Vaccine Market Share by Type in 2023 & 2030

Figure 4. DNA Product Picture

Figure 5. Non-replicating Viral Vector Product Picture

Figure 6. Protein Subunit Product Picture

Figure 7. RNA Product Picture

Figure 8. Others Product Picture

Figure 9. Global Monkeypox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Monkeypox Vaccine Market Share by Application in 2023 & 2030

Figure 11. Aldult

Figure 12. Child

Figure 13. Global Monkeypox Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Monkeypox Vaccine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Monkeypox Vaccine Sales (2019-2030) & (K Units)

Figure 16. Global Monkeypox Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 17. Monkeypox Vaccine Report Years Considered

Figure 18. Monkeypox Vaccine Sales Share by Manufacturers in 2023

Figure 19. Global Monkeypox Vaccine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Monkeypox Vaccine Players: Market Share by Revenue in 2023

Figure 21. Monkeypox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Monkeypox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Monkeypox Vaccine Sales Market Share by Country (2019-2030)

Figure 24. North America Monkeypox Vaccine Revenue Market Share by Country (2019-2030)

Figure 25. United States Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Monkeypox Vaccine Sales Market Share by Country (2019-2030)

Figure 28. Europe Monkeypox Vaccine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Monkeypox Vaccine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Monkeypox Vaccine Revenue Market Share by Region (2019-2030)

Figure 36. China Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Monkeypox Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Latin America Monkeypox Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Monkeypox Vaccine Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Monkeypox Vaccine Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Monkeypox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Monkeypox Vaccine by Type (2019-2030)

Figure 56. Global Revenue Market Share of Monkeypox Vaccine by Type (2019-2030)

Figure 57. Global Monkeypox Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Monkeypox Vaccine by Application (2019-2030)

Figure 59. Global Revenue Market Share of Monkeypox Vaccine by Application (2019-2030)

Figure 60. Global Monkeypox Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 61. Monkeypox Vaccine Value Chain

Figure 62. Monkeypox Vaccine Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions